Home / Journals / CJU / Vol.30, No.6, 2023
Special Issues
  • Open AccessOpen Access

    EDITORIAL

    The Left Shift in Drugs for Advanced Prostate Cancer

    Leonard G. Gomella
    Canadian Journal of Urology, Vol.30, No.6, pp. 11708-11709, 2023
    Abstract This article has no abstract. More >

  • Open AccessOpen Access

    LEGENDS IN UROLOGY

    LEGENDS IN UROLOGY

    Herbert Lepor
    Canadian Journal of Urology, Vol.30, No.6, pp. 11710-11712, 2023
    Abstract This article has no abstract. More >

  • Open AccessOpen Access

    BOOK REVIEW

    Infertility in the Male, 5th Edition

    Larry I. Lipshultz
    Canadian Journal of Urology, Vol.30, No.6, pp. 11713-11713, 2023
    Abstract This article has no abstract. More >

  • Open AccessOpen Access

    ARTICLE

    Impact of COVID-19 pandemic on ambulatory urologic oncology surgeries

    Zhiyu Qian1,2, Jamie Ye2, David F. Friedlander3, Mara Koelker1,2, Muhieddine Labban1,2, Bjoern Langbein1,2, Cheryl Chang-Rong Chen1,2, Mark A. Preston1,2, Timothy Clinton1, Matthew Mossanen1,2, Firas Abdullah4,5, Stuart R. Lipsitz2, Adam S. Kibel1,2, Quoc-Dien Trinh1,2, Alexander P. Cole1,2
    Canadian Journal of Urology, Vol.30, No.6, pp. 11714-11723, 2023
    Abstract Introduction: Robot-assisted laparoscopic prostatectomy (RALP) and transurethral resection of bladder tumor (TURBT) are two common surgeries for prostate and bladder cancer. We aim to assess the trends in the site of care for RALP and TURBT before and after the COVID outbreak.
    Materials and methods: We identified adults who underwent RALP and TURBT within the California Healthcare Cost and Utilization Project State Inpatient Database and the State Ambulatory Surgery Database between 2018 and 2020. Multivariable analysis and spline analysis with a knot at COVID outbreak were performed to investigate the time trend and factors associated with ambulatory… More >

  • Open AccessOpen Access

    ARTICLE

    The value of residency program characteristics changes throughout urology training

    John R. Heard1, Karl-Ray Jeune2, John M. Masterson1, Peris R. Castaneda1, Andrew G. Winer2, Andrew L. Freedman1
    Canadian Journal of Urology, Vol.30, No.6, pp. 11724-11731, 2023
    Abstract Introduction: The purpose of this study was to determine which characteristics of urology residency programs are most highly valued by medical students and residents, and how these change during training.
    Materials and methods: We distributed a survey to urology residents and medical students interested in urology via program director email and social media. The survey collected demographic data, future career plans, and asked respondents to rank the relative importance of six categories of residency program characteristics and specific characteristics within each category.
    Results: Among the six categories of residency characteristics, resident experience was ranked most important by both… More >

  • Open AccessOpen Access

    REVIEW

    Pentosan polysulfate and a pigmentary maculopathy: causation versus correlation?

    Jeffrey G. Proctor
    Canadian Journal of Urology, Vol.30, No.6, pp. 11732-11739, 2023
    Abstract Introduction: Interstitial cystitis (IC) is a chronic disease with urinary tract symptoms and pain. Pentosan polysulfate (PPS) is the only U.S. Food and Drug Administration approved oral medication for the treatment of IC pain and symptoms. Recently, articles described a pigmentary maculopathy in IC patients on long term PPS therapy. Currently, there is no definitive study directly linking PPS as the cause of the pigmentary maculopathy. The aim of this review is to evaluate if PPS is the causative factor of the pigmentary maculopathy or if PPS use is only associated with the pigmentary maculopathy.
    Materials andMore >

  • Open AccessOpen Access

    COMMENTARY

    Re: Pentosan polysulfate and a pigmentary maculopathy: causation versus correlation?

    Robert J. Evans, Raymond Xu
    Canadian Journal of Urology, Vol.30, No.6, pp. 11740-11740, 2023
    Abstract This article has no abstract. More >

  • Open AccessOpen Access

    ARTICLE

    Peri-prostatic nerve block using Clarius EC7 HD3 handheld ultrasound guidance

    Aalya Hamouda1, Ahmed Ibrahim2, Nicholas Corsi3, Dean S. Elterman4, Bilal Chughtai5, Naeem Bhojani2, Kevin C. Zorn2
    Canadian Journal of Urology, Vol.30, No.6, pp. 11741-11746, 2023
    Abstract Transrectal ultrasound (TRUS) is a common modality used during urological procedures that require real-time visualization of the prostate, such as prostate biopsy and peri-prostatic nerve blocks (PNB) for surgical procedures. Current practice for TRUS-guided PNB requires use of costly, fixed, and non-portable ultrasound machinery that can often limit workflow. The Clarius endocavity EC7 probe, a digital, handheld and pocket-sized endocavity ultrasound (US) device, is an alternative, portable technology which was recently shown to accurately visualize and measure prostate dimensions and volume. Moreover, in recent years, there has been a renaissance of office-based treatments for minimally… More >

  • Open AccessOpen Access

    RESIDENT’S CORNER

    Bladder metastasis from inflammatory breast cancer presenting with hematuria and hydronephrosis

    Halle E. Foss1, Jessica Bulafka1, Nneamaka Nwaoduah2, Mihir S. Shah1
    Canadian Journal of Urology, Vol.30, No.6, pp. 11747-11751, 2023
    Abstract We report a rare case of a 56-year-old Ukrainian female with inflammatory breast cancer (IBC) who underwent neoadjuvant chemoradiation and left radical mastectomy with her clinical course complicated by disease recurrence with bone and bladder metastases 2.5 years after her initial diagnosis. We highlight the presentation and diagnosis of genitourinary involvement of metastatic IBC, which has not previously been described in the literature. More >

  • Open AccessOpen Access

    RESIDENT’S CORNER

    Recurring cystitis cystica and cystitis glandularis masquerading as urothelial carcinoma

    Kerith R. Wang1, Rishabh K. Simhal2, Gabriel G. Dinatale3, Li Li3, Thenappan Chandrasekar4
    Canadian Journal of Urology, Vol.30, No.6, pp. 11752-11755, 2023
    Abstract We report a rare case of cystitis cystica and glandularis mimicking low-grade urothelial carcinoma that was found incidentally and treated with resection and fulguration via transurethral resection of bladder tumor (TURBT). When early recurrence was found on surveillance cystoscopy 3 months later, the patient was treated with repeat TURBT and intravesical gemcitabine. Surveillance cystoscopy 4 months later revealed cystitis cystica and cystitis glandularis yet again. We highlight the diagnosis and management of multiple early recurrences of cystitis cystica in this patient, particularly our treatment with gemcitabine and close surveillance. More >

  • Open AccessOpen Access

    HOW I DO IT

    How I Do It: Transcutaneous tibial nerve stimulation TENSI+ system

    Jean-Nicolas Cornu1, Hashim Hashim2, Frank Van Der Aa3, Cosimo De Nunzio4, Valentina Garcia Perez5, Roseanne Ferreira6, Dean S. Elterman6
    Canadian Journal of Urology, Vol.30, No.6, pp. 11756-11761, 2023
    Abstract Overactive bladder (OAB) is a common condition that significantly impacts the quality of life (QoL), well being and daily functioning for both men and women. Among various treatments, peripheral tibial nerve stimulation (PTNS) emerges as an effective third-line treatment for OAB symptoms, with options for either a percutaneous approach (P-PTNS) or by transcutaneous delivery (T-PTNS). Recent studies have shown negligible differences between P-PTNS and T-PTNS efficacy in alleviating urinary urgency and frequency and QoL improvement and, overall no difference in efficacy over antimuscarinic regimens. The TENSI+ system offers a cutting-edge transcutaneous approach, allowing patients to More >

Per Page:

Share Link